Back to search results

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

Abroad (travel likely)RecruitingPHASE2

Conditions

Interstitial Cystitis · Bladder Pain Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • IC Study LLC, Escondido, California, United States

  • University of California Los Angeles Center for Women's Pelvic Health, Los Angeles, California, United States

  • The Clark Center for Urogynecology, Newport Beach, California, United States

  • The Continence Center Medical Group, Inc dba Southern California Continence Center, Newport Beach, California, United States

  • University of California San Diego Medical Center, San Diego, California, United States

  • Prestige Medical Group, Tustin, California, United States

  • United Research Institute, Hialeah, Florida, United States

  • Florida Urology Partners, Tampa, Florida, United States

  • Georgia Urology, Cartersville, Georgia, United States

  • Southern Clinical Research Associates LLC, Metairie, Louisiana, United States

  • Bay State Clinical Trials, Watertown, Massachusetts, United States

  • Sheldon Freedman MD LTD, Las Vegas, Nevada, United States

  • Northwell Health, Lake Success, New York, United States

  • The Wake Forest Institute of Regenerative Medicine, Winston-Salem, North Carolina, United States

View source on ClinicalTrials.gov(opens in a new tab)